Chest pain and shortness of breath are common symptoms that send tens of thousands of heart failure (HF) patients into U.S. hospitals each month. Cardiologists at the Bluhm Cardiovascular Institute of Northwestern Memorial Hospital may be able to curb such visits for some of their HF patients as they recently became Chicago's first researchers using a new wireless pressure sensor technology that allows them to track the pulmonary artery pressure of the subjects while these subjects remain at home.
"Some heart failure patients spend a lot of time in and out of the hospital due to chest pain and trouble breathing," says John B. O'Connell, MD, co-director of the Bluhm Cardiovascular Institute, director of its Center for Heart Failure and professor of medicine at Northwestern University's Feinberg School of Medicine. "At any time, such as when the subject is beginning to feel poorly, we immediately get readings of pulmonary pressure. We are hopeful we can avoid a hospitalization by adjusting the subject's medication based on the pressure recording. As we evaluate the CardioMEMS Wireless Pressure Monitoring System, we see great potential to increase convenience to patients and hospital efficiency by cutting back on frequent trips to the emergency room."
The implanted pressure sensor is about the size of a standard paperclip. It is implanted into the subject's pulmonary artery through a catheter-based procedure from the groin region. The technology that allows for subjects to get readings remotely from home is a proprietary electronic monitoring system that works when they lie on a pillow containing an antenna that interacts with the implanted device to get readings on heart and lung pressures. Northwestern Memorial has implanted three subjects to date and seven more are planned as part of the CHAMPION (CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Patients) clinical study.
As O'Connell explains, when your heart doesn't pump normally, adequate blood (oxygen and nutrients) may not reach your body tissues. When this occurs, the body believes that there is not enough fluid inside its vessels. The body's hormone and nervous systems try to make up for this (or compensate) by holding on to sodium and water in the body, and by increasing heart rate—all of which are symptoms often seen in HF patients, but in many cases, can be managed with medication. The back pressure in the lungs due to the inability of the heart to pump the blood effectively can be measured and transmitted by this device.
With this system, pressure data is transmitted to a secure database that makes the data available to physicians from a proprietary Web site. Data can also be made available to physicians on a handheld device, like a BlackBerry for instance.
Source: Northwestern Memorial Hospital
Related stories:
Conclusive evidence that tainted heparin caused allergic reactions
(PhysOrg.com) -- A team of researchers has confirmed that a contaminant found in several batches of the blood-thinner heparin is linked with severe allergic reactions in patients, dozens of whom died after receiving the tainted drug.
Researcher develops screening tool to identify patients with prediabetes
A third of Americans with diabetes do not know that they have it, and many more who have prediabetic conditions are unaware that they are at risk. A University of Missouri researcher has created a clinical tool to identify those at highest risk for having undetected hyperglycemia, impaired fasting glucose (IFG) and undiagnosed diabetes. If these conditions are identified early, patients may benefit from preventative strategies that can minimize progression to diabetes, other diseases and mortality.
Study finds treatment fails to improve common form of heart failure
A medication used for high blood pressure does not improve a common form of heart failure, according to new results from a large, international study.
Have numbness, pain or muscle weakness? Guidelines identify best tests for neuropathy
New guidelines developed by the American Academy of Neurology find a combination of blood tests and other specialized assessments appear to be the most helpful tests for finding the cause of neuropathy. Also known as neuritis or distal symmetric polyneuropathy, this common nerve problem affects people of all ages. The guidelines are published in the December 3, 2008, online issue of
Neurology, the medical journal of the American Academy of Neurology.
A spoonful of sugar?
The widespread problem of children failing to take their medication for a range of life-threatening illnesses is to be tackled as part of a new university research project.
Cardiovascular disease causing increasing inequity between rich and poor
A new paper released today by The George Institute for International Health is warning a cardiovascular disease based epidemic is gaining pace among many low- and middle-income countries (LMIC), exemplified at its worst in the world's largest populated countries – China and India. Preventive cardiovascular treatments that are widely available in high income countries are not yet widely accessed in LMIC, contributing to an escalating inequality in health status between rich and poor. Cardiovascular disease was the leading cause of death globally in 2005 with more than 80% of these deaths occurring in LMIC. In China, stroke, chronic obstructive airways diseases, cancer and heart disease are the four highest contributors to the country's total disease burden almost half of these are due to cardiovascular disease.
Mini heart attacks lessen damage from major ones
Researchers have discovered one potential mechanism by which briefly cutting off, then restoring, blood flow to arteries prior to a heart attack lessens the damage caused, according to a study published today in the journal
Cardiovascular Research. The new mechanism points to how future drugs could provide protection ahead of heart attacks and strokes for those at highest risk. In the nearer term, the work may help to prevent damage caused as U.S. heart surgeons temporarily cut off blood flow 450,000 times each year to perform coronary artery bypass graft surgeries. Lastly, the discoveries hold clues to the value of the Mediterranean diet beyond red wine.
If Cheaper is Better to Treat Hypertension Then Why Aren't More Patients Prescribed Low Cost Diuretics
(PhysOrg.com) -- An independent study comparing a low cost diuretic to ACE inhibitors, calcium blockers and alpha blockers for the treatment of high blood pressure and hypertension was sponsored by the National Heart, Lung and Blood Institute. The study entitled Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) was conducted for the period of 1994 to 1998 with the last follow-up visit in March, 2002.